CDERLearn Training and Education
Learning opportunities for healthcare professionals, academia, students, and consumers
Search General Courses Search Industry Courses
Upcoming Free CE Opportunities
- May 15: A Deep Dive: GDUFA III Scientific Meetings
- May 16: OTC Monograph Drug User Fee Program (OMUFA): Understanding FY 2023 User Fees and Registration
- May 23: FDA Drug Topics: How to Avoid Medication Errors with Pen Injectors
- May 24: An Update on Field Alert Reports (FAR) and Biological Product Deviation Reports (BPDR)
| Summary | Type | Topic |
|---|---|---|
| FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use | Health Care Professionals; Patients; Podcasts | Drug Development; Drug Regulatory Process; Drug Safety; MedWatch; Opioids |
| FDA approval of Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Zynyz (retifanlimab-dlwr) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Compounding Quality Center of Excellence Annual Conference | Health Care Professionals, Patients, Podcasts, Social Media, Webinars | Compounding, COVID-19, Drug Development, Drug Regulatory Process, Drug Safety |
| Conversations on Cancer: “Cancer Misinformation: Truth or Consequences” | Case Study, Health Care Professionals, Patients, Podcasts, Social Media, Webinars | Cancer Drugs, Disease States, Drug Development, Drug Regulatory Process, Drug Safety |
| Stability and Beyond Use Dates | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
| FDA approval of Tafinlar (dabrafenib) with Mekinist (trametinib) for pediatric patients with low-grade glioma with a BRAF V600E mutation | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Verzenio (abemaciclib) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Jemperli (dostarlimab-gxly) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Trodelvy (sacituzumab govitecan-hziy) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approvals of Jaypirca (pirtobrutinib) and Orserdu (elacestrant) | Health Care Professionals; Patients; Podcasts; Women’s Health | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approval of Keytruda (pembrolizumab) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA approvals of Tukysa (tucatinib) | Health Care Professionals; Patients; Podcasts | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars: What Patients Need to Know | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilars: What Patients With Diabetes Need To Know | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilar Basics | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilares: Lo que los pacientes deben saber | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilares: Lo que los pacientes con diabetes deben saber | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Conceptos básicos sobre los biosimilares | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Biosimilar Basics for Patients | Patients; Graphics | Biosimilars; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Airflow | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Personnel Gowning in Sterile Drug Production | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Insanitary Conditions and Sterility Assurance | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Supplier/Contractor Qualification and Management | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Investigations and Corrective and Preventive Actions (CAPA) | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Outsourcing Facility Guide | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Sterility Testing: Common Misconceptions | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Regulatory Framework for Human Drug Compounding | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Aseptic Process Simulations (Media Fills) | Health Care Professionals; Graphics; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| MedWatch, Your Report Can Make a Difference with Dr. Gerald Dal Pan | Health Care Professionals; Podcasts | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
| Expanded Access with Dr. Jacqueline Corrigan-Curay | Health Care Professionals; Patients; Graphics | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; IND |
| Are you on a biologic medication? | Patients; Graphics | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Summary Report for Biosimilars | Health Care Professionals; Patients; Graphics | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars Multimedia Education Materials | Health Care Professionals; Patients; Graphics; Podcasts; Social Media; Videos; Webinars | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars Overview for Health Care Professionals | Health Care Professionals; Graphics; Podcasts; Videos; Webinars | Biosimilars; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| FDA 101: An Overview of FDA's Regulatory Review and Research Activities | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; OTC Drug Regulations; Women’s Health |
| FDA Insight | Health Care Professionals; Patients; Podcasts | Compounding; COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; Opioids; Women’s Health; OTC Drug Regulations |
| Health Equity Forum Podcast | Health Care Professionals; Patients; Podcasts | COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Diabetes; Women’s Health |
| MedWatch, Your Report Can Make a Difference | Health Care Professionals; Patients; Podcasts | Drug Safety; MedWatch; Generic Drugs; Disease States; Drug Regulatory Process |
| Pregnancy and Lactation Medication Information for the Healthcare Provider | CE Credits; Health Care Professionals; Webinars; Videos; Social Media | Women’s Health; Disease States; Drug Regulatory Process; Drug Safety |
| Minority Health and Health Equity Webinars | Health Care Professionals; Patients; Podcasts; Videos; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Why Does the FDA Exist? | Health Care Professionals; Patients; Videos; Podcasts; Social Media | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Achieving Data Quality and Integrity in Maximum Containment Laboratories | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; |
| Topics in Public Health | CE Credits; Health Care Professionals; Patients; Case Study; Webinars | Biomarker; Biosimilars; Cancer Drugs; Compounding; COVID-19; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Opioids; OTC Drug Regulations; Women's Health |
| Conversations on Cancer: "What’s on the Horizon: Future of Cancer Care" | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States |
| Conversations on Cancer: “Seasons of Change: Oncology Careers” | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States |
| Application of Artificial Intelligence and Machine Learning for Precision Medicine | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Joint US FDA – Health Canada ICH Public Meeting | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; IND |
| FDA Rare Disease Day 2023 | Health Care Professionals; Patients; Webinars | Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Risk Evaluation and Mitigation Strategies (REMS) Program Part 1 | Health Care Professionals; Patients; Graphics | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| Risk Evaluation and Mitigation Strategies (REMS) Program Part 2 | Health Care Professionals; Patients; Graphics | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs |
| International 2022 Drug-Induced Kidney Injury Biomarker Workshop Day 1 and Day 2 | Health Care Professionals; Patients; Videos | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Advancing Regulatory Science at FDA | Health Care Professionals; Patients; Graphics | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Accelerating Access to Critical Therapies for ALS | Health Care Professionals; Patients; Graphics; Videos | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Accelerating Rare disease Cures (ARC) Program | Health Care Professionals; Patients; Videos | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| Successes and Opportunities in Modeling and Simulation for FDA | Health Care Professionals; Patients; Graphics | Biomarker; Disease States; Drug Development; Drug Regulatory Process |
| FDA’s Work to Combat the COVID-19 Pandemic | Health Care Professionals; Patients; Graphics | COVID-19; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Working with patient advocacy groups | Health Care Professionals; Patients; Podcasts | Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Drug compounding | Health Care Professionals; Patients; Podcasts | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Talking translational science | Health Care Professionals; Patients; Podcasts | Biomarker; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Addressing the Opioid Epidemic | Health Care Professionals; Patients; Podcasts | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids |
| Antibiotic Misuse and Resistance | Health Care Professionals; Patients; Podcasts | Disease States; Drug Safety; MedWatch |
| FDA's Adverse Event Reporting System (FAERS) | Health Care Professionals; Patients; Podcasts | Drug Safety; MedWatch; Generic Drugs |
| Breakthrough Therapy Designation | Health Care Professionals; Patients; Podcasts | Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Biosimilars: Are they the same quality? | Health Care Professionals; Patients; Graphics | Biosimilars; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
| How to Use the Consumer Complaint System and MedWatch | Health Care Professionals; Patients | Drug Safety; MedWatch |
| Reporting Unlawful Sales of Medical Products on the Internet | Health Care Professionals; Patients | Drug Safety |
| Health Fraud Product Database | Health Care Professionals; Patients | Drug Safety |
| Compounding Outsourcing Facilities Annual Study | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Compounding Quality Center of Excellence Virtual Conference | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| State of Outsourcing Facility Sector and Possibilities for the Future | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Areas of Customer Need for Outsourcing Facility Products | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Compounding Quality Center of Excellence Cross-Sector | Health Care Professionals; Patients; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety |
| Compounding Quality Center of Excellence Virtual Live Training | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
| Equity of Voices video series | Health Care Professionals; Patients; Case Study; Podcasts; Videos; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
| Biosimilars in the Real World: Perspectives for Staying Within the Scope of Care | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch |
| Pregnancy and Lactation Medication Information for the Healthcare Provider: | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
| Leveraging Real-World Data to Study Medication Use in Pregnancy and Lactation | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
| CBD and Other Cannabinoids: Sex and Gender Differences in Use and Responses | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health |
| Opioid and Nicotine Use, Dependence, and Recovery: Influences of Sex and Gender | Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Opioids; Women's Health |
| Maximizing Benefits and Minimizing Harms from Antibiotics | Health Care Professionals; Patients; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch |
| Health Fraud Scams | Health Care Professionals; Patients; Webinars | Drug Safety |
| 6 Tip-Offs to Rip-Offs: Don't Fall for Health Fraud Scams | Health Care Professionals; Patients; Webinars | Drug Safety |
| BeSafeRx: Your Source for Online Pharmacy Information | Health Care Professionals; Patients; Webinars | Drug Safety |
| Health Care Professionals; Patients; Podcasts; Videos | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch | |
| FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska | Health Care Professionals; Patients; Podcasts | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Opioids; Cancer Drugs |
| FDA Health Playbook | Health Care Professionals; Patients; Videos; Graphics; Podcasts; Social Media | Drug Safety; OTC Drug Regulations; MedWatch; Opioids |
| 14th Annual Sentinel Initiative Public Workshop | Health Care Professionals; Patients; Webinars | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
| Medical Extended Reality: Applications and Challenges | Health Care Professionals; Patients; Webinars | Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
|
Highlights in Oncofertility: Trends in an Emerging Field for Cancer Survivors |
Health Care Professionals; Patients; Webinars | Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Women’s Health |
| What does FDA regulate? | Health Care Professionals; Patients; Videos; Graphics | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; OTC Drug Regulations; Women’s Health |
| FDA Grand Rounds | Health Care Professionals; Patients; Webinars | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; Biosimilars; IND; Cancer Drugs; Biomarker; Women’s Health |
| Safe Opioid Disposal | Safe Opioid Disposal - Remove the Risk Outreach Toolkit | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; Cancer Drugs; Opioids |
| What Does FDA Do? | Health Care Professionals; Patients; Videos | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch; Generic Drugs; OTC Drug Regulations; IND; Women’s Health |
| Conversation on Paxlovid with Dr. John Farley | Health Care Professionals; Patients; Podcasts | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety |
| Clinical Trial Basics with Dr. Robert Temple | Health Care Professionals; Patients; Podcasts | Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Biomarker; Women’s Health |
| Biosimilars Patient Materials | Graphics; Videos; Patients | Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
| Clinical Trial Basics | Health Care Professionals; Podcasts | Biomarkers; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; IND; Women’s Health |
| Adverse Events Associated with Compounded Drugs from Outsourcing Facilities | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
| Biosimilars 101: A Primer for Your Practice | CE Credits; Health Care Professionals; Case Study | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Incorporating Biosimilars Into the Management of Patients With Immunological Conditions | CE Credits; Health Care Professionals; Case Study | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Putting the Patient into Perspective: Strategies for Educating Patients about Biosimilars | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Biosimilars Resources | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
| Bridging Efficacy and Safety to the Obese | Health Care Professionals; Webinars | Biomarker; Cancer Drugs; Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND; MedWatch; Women's Health |
| Engaging Providers to Address Knowledge Gaps on Medication Use in Pregnancy and Lactation | CE Credits; Health Care Professionals; Webinars | Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; MedWatch; Women's Health |
| Biosimilars Videos | Healthcare Professionals; Videos Biosimilars; Drug Regulatory Process | Drug Development |
| Biosimilars Level 2: Regulatory and Scientific Concepts | Case Study | Health Care Professionals |
| Biosimilars Level 1: Foundational Concepts | Case Study | Health Care Professionals |
| Increasing the Efficiency of Biosimilar Development Programs | Health Care Professionals; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
| Successfully Navigating the USPTO and FDA | CE Credits; Webinars | Drug Development; Drug Regulatory Process; Drug Safety; Registration and Listing |
| The History of FDA | Health Care Professionals; Webinars | Drug Development; Drug Regulatory Process; Drug Safety |
| Bench to Bedside: Integrating Sex and Gender to Improve Human Health | CE Credits; Health Care Professionals; Webinars | Diabetes; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; Women's Health |
| Q&A with FDA | Health Care Professionals; Podcasts | COVID-19; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; MedWatch |
| Biosimilars Level 1: Foundational Concepts | Health Care Professionals; Case Study | Biosimilars; Drug Regulatory Process; Drug Development |
| Biosimilars Level 2: Regulatory and Scientific Concepts | Health Care Professionals; Case Study | Biosimilars; Drug Regulatory Process; Drug Development |
| Biosimilars Curriculum Materials | Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Biosimilars; Drug Regulatory Process; Drug Development |
| Drug Approval Case Studies | Case Study; Health Care Professionals; Patients; Graphics | Diabetes; Drug Development; Drug Regulatory Process; Drug Safety; Generic Drugs; IND |
| FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond | Health Care Professionals; CE Credits | Drug Regulatory Process |
| Practitioners’ Guide for Improving Oral Anticoagulant Use | Health Care Professionals; CE Credits | Oral Anticoagulant; Disease States |
| The FDA Bad Ad Program and Prescription Drug Promotion | Health Care Professionals; CE Credits | Prescription Drug Promotion |
| FDA MedWatch and Patient Safety | Health Care Professionals | MedWatch; Drug Safety |
| The FDA Process for Approving Generic Drugs | Health Care Professionals | Drug Regulatory Process; Drug Development; Generic Drugs |
| FDA Overview of Biosimilar Products | Health Care Professionals; Videos | Biosimilars; Drug Regulatory Process; Drug Development |
| Leveraging Health Literacy and Patient Preferences to Reduce Hypoglycemia Events in Patients with Type 2 Diabetes | Health Care Professionals | Diabetes; Disease States |
| Director's Corner Podcasts | Health Care Professionals; Podcasts | Drug Regulatory Process; Drug Development; Compounding; Generic Drugs; Drug Safety; MedWatch; Disease States |
| Drug Information Soundcast in Clinical Oncology (D.I.S.C.O) | Health Care Professionals; Podcasts | Cancer Drugs; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| FDA Drug Safety Podcasts | Health Care Professionals; Podcasts | Drug Safety; Biosimilars; Cancer Drugs; Diabetes; Disease States; Drug Regulatory Process; Drug Development; Drug Safety; Generic Drugs; MedWatch; Women’s Health |
| Regulatory Science at CDER Podcasts | Health Care Professionals; Podcasts | Drug Development; Disease States; Drug Regulatory Process; Drug Safety; IND |
| FDA's Biomarker Qualification Program | Videos | Biomarker; Drug Development |
| Biosimillars Health Care Provider Materials | Health Care Professionals; Videos; Graphics; Social Media | Biosimilars; Drug Regulatory Process; Drug Development; Disease States; Drug Safety |
| FDA Drug Info Rounds | Health Care Professionals; Videos | Drug Safety; MedWatch; IND; Drug Development; Drug Regulatory Process; Prescription Drug Promotion; Disease States; Registration and Listing; Generic Drugs |
| GDUFA II Videos and Resources | Videos | Drug Development; Generic Drugs |
| Regulatory Science at CDER Videos | Videos | Drug Regulatory Process; Drug Development |
| Biosimilars Online Courses, Webinars, and Presentations | Health Care Professionals; Webinars | Biosimliars; Drug Regulatory Process; Drug Development |
| CDER Webinars | Health Care Professionals; Webinars | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Registration and Listing; Electronic Submissions; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
| Division of Drug Information Webinars | Health Care Professionals; Webinars; CE Credits | Drug Regulatory Process; Drug Development; Generic Drugs; OTC Drug Regulations; Biosimilars; Drug Safety; MedWatch; IND; Disease States; Prescription Drug Promotion; Cancer Drugs |
| Compounding Quality Center of Excellence On-Demand Training | CE Credits; Health Care Professionals; Case Study; Podcasts; Videos; Webinars | Compounding; Disease States; Drug Development; Drug Regulatory Process; Drug Safety; MedWatch |
Additional Resources
- FDA Continuing Education Programs
- Training and Continuing Education
- FDA Learning Portal for Students, Academia, and Industry
- For questions contact CDER Division of Drug Information
Sub-Topic Paragraphs
Paragraph Header
Contact Us
Paragraph Header
Contact Us
Contact Point
Office of Communications
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
10001 New Hampshire Ave
Hillandale Building, 4th Fl
Silver Spring, MD 20993
Toll Free
(855) 543-3784
(301) 796-3400
Hours Available
CDER Division of Drug Information
For Updates on Twitter follow
Contact Point Twitter
@FDA_Drug_Info
Your source for the latest drug information.
Know the moment it happens.